How Long Do Menopause Symptoms Last? By Symptom [2026]

How long do menopause symptoms last? They do not share one clock. Frequent hot flashes and night sweats lasted a median 7.4 years in the strongest long-term U.S. study and 4.5 years after the final period. Other symptoms may improve, persist, or worsen without treatment, so the useful answer depends on the symptom—not one universal average.

This page is for you if

You're still having symptoms and want to know what the research actually says about how long they can run. Or your periods stopped and the symptoms didn't. Or you're deciding whether to treat them or wait. Or you're taking hormone therapy and wondering what may happen when you stop.

This page isn't enough on its own if

• You've had any bleeding or spotting 12 or more months after your last period. That needs medical evaluation. It does not belong on a symptom timeline.
• You're trying to work out whether you're in perimenopause at all — start with our perimenopause symptoms checklist.
• You want the duration of the perimenopause stage, which is a different clock — see how long perimenopause lasts.
• Your periods stopped before age 40, you had both ovaries removed, or treatment has suppressed your cycle. Those situations need an individual clinical conversation.

If you searched how long do menopause symptoms last because you've already been at this longer than anyone told you to expect, here's the part that may finally make the numbers make sense: you may not be an outlier. You may have been handed a number that was measuring a different symptom, a different starting line, or a different group of women.

What you're actually measuring

The question you're asking	The best-supported answer
How long does perimenopause last?	Usually 2–8 years; about 4 years for most women
How long do frequent hot flashes and night sweats last, start to finish?	Median 7.4 years
How long do frequent hot flashes and night sweats last after the final period?	Median 4.5 years
What if frequent hot flashes started before cycle changes or in early perimenopause?	Median more than 11.8 years total; the study could not calculate a finite median within its observation window
Vaginal dryness, painful sex, urinary urgency, or recurrent urinary infections?	GSM often persists and usually worsens over time without treatment
Brain fog, mood, sleep, joint pain, fatigue, or libido changes?	No single dependable universal countdown; each needs its own evidence and, sometimes, another explanation

Source: The HRT Index Editorial Team; see the primary sources linked in this section.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

---

How long do menopause symptoms last on average?

There is no single honest average for all menopause symptoms. The strongest duration estimate is a median of 7.4 years for frequent hot flashes and night sweats, with a median 4.5 years continuing after the final menstrual period. Other symptoms follow different courses, and several do not have a reliable personal end point at all.

That 7.4-year figure comes from SWAN — the Study of Women's Health Across the Nation. The multiracial and multiethnic U.S. cohort enrolled 3,302 women at seven sites and followed them from 1996 through 2013. The duration analysis published in JAMA Internal Medicine included 1,449 women who reported frequent hot flashes or night sweats. Participants completed a median of 13 study visits. (Avis et al., 2015)

That word frequent is doing a lot of work, and almost nobody explains it.

In the analysis, frequent vasomotor symptoms meant hot flashes or night sweats on at least six days in the previous two weeks. Not one flash a month. Not the occasional warm evening. Six days out of fourteen, reported repeatedly across years of study visits.

So when a website says menopause symptoms last about seven years, what it should say is this:

Among women who reported hot flashes or night sweats on at least six days in the prior two weeks, the estimated median time from the first qualifying report to the end of frequent symptoms was 7.4 years.

Two more things that number does not say:

It's a median, not a deadline. It is the estimated midpoint of the distribution, not a maximum and not the date by which your symptoms are supposed to be over. Being past year 7.4 does not make you a medical anomaly.

It doesn't mean 7.4 years at the same intensity. Symptom courses fluctuate. Women were not having identical numbers or severities of flashes for 2,700 straight days. A quieter stretch can be followed by a worse one, especially through the transition.

Here's the part that matters more than the headline number: 7.4 years describes frequent hot flashes and night sweats. It does not describe brain fog, joint pain, sleep disruption, libido changes, vaginal dryness, fatigue, or every symptom that happens during midlife.

---

Why does every website give you a different number?

Duration estimates range from about four years to fourteen because public pages often measure different things: the perimenopause stage, the total course of frequent hot flashes, or years of hot flashes after menopause. Some also leave the symptom threshold and starting point unstated. The numbers are not interchangeable, even when they appear beside the same word: menopause.

Here's the clearest example, and it's a strange one because it involves federal health pages.

The National Institute on Aging says symptoms related to menopause can last between two and eight years. The Office on Women's Health says perimenopause itself lasts two to eight years for most women, while another part of the same current page says hot flashes after menopause continue for an average of nine years and may last up to fourteen. (National Institute on Aging; Office on Women's Health, updated April 2026)

If you read those statements back to back, you'd reasonably conclude that nobody knows anything.

The problem is not that every number is necessarily false. The problem is that the ruler is often hidden.

Source or study	What the wording is counting	Published answer	What you must not turn it into
Office on Women's Health	Perimenopause, the transition before periods stop	2–8 years; about 4 years for most	The duration of every symptom
National Institute on Aging	Broad public-facing statement about menopause-related symptoms	2–8 years	A symptom-specific countdown without a defined threshold
Office on Women's Health	Hot flashes continuing after menopause	Average 9 years; may last up to 14	The duration of brain fog, sleep, joint pain, GSM, or all symptoms combined
SWAN / JAMA Internal Medicine	Total course of frequent hot flashes or night sweats	Median 7.4 years	An average for all menopause symptoms
SWAN, observable-final-period subgroup	Frequent hot flashes or night sweats after the final period	Median 4.5 years	A promise that symptoms stop 4.5 years later
SWAN, earliest-onset group	Frequent VMS beginning before cycle changes or in early perimenopause	Median more than 11.8 years total; 9.4 years after the final period	A prediction for every woman whose first flash came early

Source: The HRT Index Editorial Team; see the primary sources linked in this section.

Different starting lines. Different finish lines. Different symptom thresholds. Sometimes different study populations. Of course they do not match.

The rule we apply to every duration figure on this page

Before we publish a duration number, it has to carry:

1. The symptom measured
2. The threshold that counted as having it
3. The starting point
4. The ending point
5. Whether the number is a mean, median, maximum, or range
6. The population studied
7. The source and the date we checked it

If a number cannot carry all seven, we do not present it as your countdown.

Not sure which clock fits what you're experiencing? The HRT Index's Find My HRT Path tool uses your main symptoms, stage, treatment preferences, safety history, insurance or cash-pay situation, and state to give you a private starting-point plan. It does not diagnose menopause, and it flags when online care is not the right place to start.

---

The right online HRT provider isn't the same for every woman

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

---

Which menopause symptoms fade, persist, or worsen?

Menopause symptoms do not divide cleanly into “temporary” and “permanent.” Frequent hot flashes usually improve over time; GSM often persists and usually worsens without treatment; cognitive, mood, sleep, and joint symptoms have more variable courses and no dependable personal countdown. The safest map separates evidence about population direction from promises about an individual end date.

This is the table we built the page around. It combines the strongest available duration or trajectory evidence without pretending that a population pattern can tell one woman exactly when she will feel different.

Symptom or symptom group	Best-supported direction over time	What the evidence can tell you	What it cannot tell you
Frequent hot flashes and night sweats	Usually improve and eventually cease for many women, but can persist for years or decades in some	Median 7.4 years total and 4.5 years after the final period in SWAN	Your personal stop date or future severity
Brain fog, processing speed, verbal memory, word-finding	Some measured changes appear stage-limited and may improve after the transition	SWAN found a temporary loss of normal practice-related improvement during perimenopause; other studies found some verbal-learning difficulty into early postmenopause	That every cognitive complaint ends at menopause or that every new memory problem is hormonal
Mood symptoms and depression risk	The transition is a documented window of higher risk; population risk falls again after it	Risk of new or recurrent depression rises during the transition, especially with prior depression	That every mood symptom is caused by menopause or will resolve without treatment
Sleep problems	Many women stabilize or improve after menopause, while persistent insomnia, sleep apnea, urinary symptoms, pain, and residual VMS can continue	Sleep trajectories differ; persistent problems deserve their own assessment	A universal year when sleep returns to baseline
Joint and muscle pain	Pooled prevalence is higher in perimenopause and remains high after menopause	A 2026 meta-analysis found muscle or joint pain in 57% of perimenopausal and 59% of postmenopausal women, versus 40% before menopause	That menopause caused a particular pain, that it will stay forever, or that hormone therapy will fix it
Vaginal dryness, burning, painful sex, urinary urgency, recurrent urinary infections	Often persists and usually worsens over time without treatment	The Menopause Society describes GSM as different from hot flashes because it usually progresses untreated	That every vaginal or urinary symptom is GSM without an examination or clinical assessment
Bleeding or spotting after menopause	Not a symptom to put on a clock	It needs medical evaluation after 12 months without bleeding	That a duration average can make it safe to wait

Source: The HRT Index Editorial Team; see the primary sources linked in this section.

How to read that table

The hot-flash row has the strongest actual duration evidence. It gives you a midpoint and meaningful onset-stage differences.

The GSM row runs in the opposite direction. Waiting is not neutral when lower-estrogen tissue changes are driving the problem, because the professional guidance says the syndrome usually worsens without treatment. (The Menopause Society GSM MenoNote)

The middle rows are where false certainty grows fastest. A population can show cognitive recovery, lower depression risk after the transition, or stable postmenopausal pain prevalence without proving that your symptom has ended, stayed, or was caused by menopause in the first place.

That is the more useful distinction: not “Which symptoms definitely end?” but “Which symptoms have a measured duration, which have only a population direction, and which should not be waited out?”

---

How long do hot flashes and night sweats last after your last period?

Frequent hot flashes and night sweats continued a median 4.5 years after the final menstrual period in SWAN. Onset timing changed the course sharply: women whose frequent symptoms began before cycle changes or in early perimenopause had more than 11.8 years total and 9.4 years after the final period, while postmenopausal-onset symptoms had the shortest median course at 3.4 years.

If you take one table away from this page, make it this one. It is the reason two women can both have a documented menopause pattern and live through completely different timelines.

When frequent hot flashes or night sweats began	Median total duration	Median persistence after the final period
All women in the frequent-VMS analysis	7.4 years	4.5 years among women with an observable final period
Before cycle changes or in early perimenopause	More than 11.8 years	9.4 years
Only after menopause	3.4 years	3.4 years

Source: Avis et al., JAMA Internal Medicine, 2015.

“More than 11.8 years” is not a typo. The researchers could not estimate a finite median in that subgroup because too few women had stopped having frequent symptoms within the observed period. It is not an exact endpoint. It is evidence that the long tail is real.

Read that again, because it is the answer a lot of women are actually looking for:

Starting early doesn't get you out early. It is associated with a longer run, not a shorter one.

If your frequent hot flashes began while your cycles were still regular and you are still dealing with them ten years later, that is well within the longer course documented in the early-onset group. That is not a promise that nothing else needs checking. It is proof that the generic short timeline was never built for every onset pattern.

One hot flash versus years of hot flashes

Two different questions are called “how long do hot flashes last,” and mixing them up creates absurd answers.

One hot flash usually lasts about one to five minutes. It is a wave of heat, often across the chest, neck, and face, commonly with sweating and sometimes followed by chills. (The Menopause Society)

The hot-flash course is how many months or years you keep having episodes. That is the 7.4-year median.

So “a hot flash lasts four minutes” and “hot flashes can last seven years” can both be true. They are measuring completely different things.

Do the SWAN numbers apply after hysterectomy, ovary removal, or cycle suppression?

Not cleanly. SWAN's duration estimates centered on women moving through a natural transition with an observable final menstrual period. If bleeding stopped because your uterus was removed, if both ovaries were removed, or if medication suppresses bleeding, the study clock cannot attach to your history in the same way.

That does not make your symptoms less real. It means the last-period field cannot do a job it was never designed to do.

---

When are menopause symptoms at their worst?

Vasomotor symptoms can rise during late perimenopause and are most likely during the first two years after the final menstrual period. The 12-month menopause milestone is therefore not a guarantee that hot flashes should be over. It can land inside the peak post-period window rather than beyond it.

The staging system clinicians and researchers use is called STRAW+10. It says vasomotor symptoms are likely during the late menopause transition and most likely during the first two years of early postmenopause. (STRAW+10 executive summary)

That distinction corrects one of the cruelest misunderstandings in the whole subject.

You reach twelve months without a period. You expect relief because the milestone sounds like a finish line. Then the flashes, night sweats, or sleep disruption are still there—or worse.

That does not mean you failed menopause. It means the calendar milestone and the symptom peak are not the same event.

Bone research shows a similarly concentrated window, but it must be described precisely. In SWAN, bone-mineral-density loss began about one year before the final menstrual period and decelerated—but did not stop—about two years after it. (Greendale et al., 2012)

That does not mean hot flashes and bone loss are the same process. It means major physiologic change is still happening around the final period, including after the date you thought should have ended the disruption.

If you are in that window and deciding whether to act or wait: Find My HRT Path can organize your symptom pattern, stage, preferences, safety flags, state, and payment route before a consult. It also tells you when online care is not the right starting point.

---

Why don't vaginal dryness and urinary symptoms go away on their own?

Genitourinary syndrome of menopause—GSM—behaves differently from hot flashes. It can include vaginal or vulvar dryness, burning, irritation, painful sex, urinary urgency or frequency, and greater susceptibility to urinary infections. The Menopause Society states that GSM usually worsens over time without treatment, which makes waiting a different decision than it is for vasomotor symptoms.

GSM covers lower-estrogen changes affecting the vulva, vagina, urethra, and bladder. The older term “vaginal atrophy” was too narrow: it left the urinary symptoms and much of the external discomfort out of the name.

Now the part that matters.

Hot flashes typically improve with time. GSM usually does not follow that curve. The Menopause Society's patient guidance says it plainly: unlike hot flashes, GSM usually worsens over time without treatment. (The Menopause Society GSM MenoNote)

That is not a telehealth marketing line. It is a professional-society statement about the natural course of the syndrome.

Why this catches women off guard years later

A woman can finally see hot flashes fade, sleep somewhat settle, and then develop vaginal burning, pain with penetration, urinary urgency, or recurrent infections years into postmenopause.

If her only mental model is “menopause symptoms fade,” the new symptom feels impossible.

It can be GSM. But it still deserves the correct clinical explanation, because not every vaginal, vulvar, pelvic, or urinary symptom is caused by menopause. Infection, dermatologic conditions, pelvic-floor problems, and other causes can overlap.

What this changes about the decision to wait

For hot flashes, waiting can be a legitimate choice when symptoms are tolerable and no separate evaluation is needed. There is evidence that the symptom course usually moves toward improvement.

For GSM, waiting has a different trade-off. The syndrome usually progresses untreated. That does not mean you must accept a particular medication. It means “I'll wait until it goes away” is not backed by the same natural-history evidence.

FDA-approved and compounded products are not the same category

FDA-approved therapies used for GSM include low-dose vaginal estrogen products, vaginal prasterone, and oral ospemifene, depending on the symptom and the woman's history. A licensed clinician determines whether any option fits.

Compounded medications are not FDA-approved. FDA does not verify their safety, effectiveness, or quality before marketing, and a compounded product should not be described as equivalent to an approved drug. (FDA compounding questions and answers)

If this is your symptom, our vaginal estrogen guide covers FDA-approved local options, and using vaginal estrogen with systemic HRT covers the separate question of what to discuss when systemic therapy has not resolved local symptoms.

If vaginal or urinary symptoms are part of your picture, the care route can be different from the hot-flash route. Check your starting point with Find My HRT Path before you pay for a program that may not offer the local treatment—or the in-person examination—you actually need.

---

How long does menopause brain fog last?

There is no dependable universal countdown for menopause brain fog. SWAN found that perimenopause temporarily disrupted the normal practice-related improvement seen on repeated tests of processing speed and verbal memory, with that effect resolving after menopause. Other longitudinal research found that verbal learning could remain affected into early postmenopause even when verbal memory recovered.

The SWAN finding is more specific than the usual headline.

When people repeat the same kind of cognitive test over several years, they normally get a little better simply because they have done it before. In SWAN, women in perimenopause did not show the expected improvement on some measures of processing speed and verbal memory. In postmenopause, that practice-related improvement returned. (Greendale et al., 2009)

That maps surprisingly well to the way many women describe brain fog: not “I cannot think at all,” but “I used to be sharper than this, and I can feel the difference.”

The honest counterweight

We are not going to hand you a clean finish date because the evidence does not support one.

SWAN points toward stage-limited change in the domains it measured. The Penn Ovarian Aging Study found that verbal-memory difficulty recovered while verbal-learning difficulty persisted into early postmenopause. (Epperson et al., 2013) A 2022 clinical guide reviewing the evidence describes menopause-related cognitive complaints as common but emphasizes that the long postmenopausal tail is not well defined. (Maki et al., 2022)

So the fair answer is:

The best evidence points toward improvement in some cognitive domains, but not a universal date and not identical recovery across every domain.

The line worth knowing

The cognitive changes described in menopause studies are generally subtle. Clearly progressive decline, repeated safety mistakes, difficulty doing familiar work, getting lost in familiar places, or changes that other people are noticing deserve assessment rather than automatic attribution to menopause.

Menopause is common. It is not the explanation for everything that happens at the same age.

---

How long do sleep problems and mood changes last?

Sleep and mood do not share one course. Many women's sleep stabilizes or improves after menopause, but persistent insomnia, sleep apnea, pain, urinary symptoms, and residual night sweats can keep sleep disrupted. Depression risk behaves more like a vulnerability window: it rises during the transition compared with both premenopause and several years after it, but that does not make any individual episode self-limiting.

Sleep: population improvement does not guarantee your night gets fixed

SWAN's longitudinal work found multiple sleep trajectories. For the majority of women, sleep problems stabilized or improved after menopause; a smaller group followed a worsening path. That is useful, but it is not a personal timer. (Kravitz et al., 2017)

If your sleep is still poor years after the final period, waiting for “menopause to finish” may miss the thing that is now keeping you awake. Possibilities include:

• Persistent night sweats
• Insomnia that has taken on a life of its own
• Sleep apnea
• Pain
• Anxiety or depression
• Urinary frequency
• Medication effects

The Office on Women's Health specifically advises discussing sleep problems because insomnia and sleep apnea become important considerations in this stage. (Office on Women's Health)

The useful question changes from “How many years does menopause sleep last?” to “What is waking me now?”

Mood: a window of vulnerability, not a promise to wait

The National Institute of Mental Health describes the menopause transition as a window of vulnerability for new and recurrent depression. Rates of major depressive disorder and clinically meaningful depressive symptoms rise roughly two- to threefold during the transition compared with both premenopause and several years after menopause. A previous depressive episode is an important risk factor. (NIMH funding notice summarizing the evidence)

The word window matters. Population-level risk rises and then falls.

But that is not a reason to wait out depression. Depression is treatable at any point, and “it's probably hormones” is not a treatment plan. Mood symptoms can be influenced by hormone change, sleep loss, stress, life events, prior mental-health history, medication, and other health conditions at the same time.

If you are in the middle of it and afraid this is your permanent baseline, the population data does not support that conclusion. If you are severely depressed, unable to function, or thinking about harming yourself, the duration question is no longer the right question—seek urgent help now. In the United States, call or text 988 for the free, confidential 988 Suicide & Crisis Lifeline; call 911 if there is immediate danger.

---

How long does menopause joint pain last?

No study can give menopause-related joint or muscle pain a reliable personal end date. The strongest current prevalence evidence—a 2026 meta-analysis of 37 observational studies and 93,021 women—found muscle or joint pain in 40% before menopause, 57% during perimenopause, and 59% after menopause. The pooled prevalence did not fall after menopause, but the studies cannot prove the cause of an individual woman's pain.

Here are the current pooled figures:

Menopause stage	Pooled prevalence of muscle or joint pain
Premenopause	40% (95% CI 32%–49%)
Perimenopause	57% (95% CI 48%–65%)
Postmenopause	59% (95% CI 50%–67%)

Source: The HRT Index Editorial Team; see the primary sources linked in this section.

Compared with premenopausal women, the pooled relative risk was 1.35 in perimenopause and 1.40 in postmenopause. But the heterogeneity was high, most included studies were cross-sectional, and the authors explicitly said that specific causes were underreported. (Kruse et al., 2026)

That changes the draft answer in an important way.

The data supports “joint and muscle pain is common and remains common after menopause.” It does not support “your menopause joint pain levels off and stays forever.”

A 2024 review proposed the term musculoskeletal syndrome of menopause to draw attention to joint, muscle, tendon, bone, and connective-tissue concerns around the transition. That is a proposed clinical framework, not a validated diagnosis that explains every ache.

When joint pain isn't a menopause-duration question

Joint and muscle pain in midlife is highly multifactorial. Osteoarthritis, inflammatory arthritis, injury, sleep loss, thyroid disease, medication effects, loss of strength, weight change, and other conditions can overlap with the transition.

Patterns that belong with a clinician rather than a countdown include:

• One joint that is severely painful, swollen, red, or warm
• Matching small joints on both sides with prolonged morning stiffness
• Pain with fever, rash, swollen lymph nodes, or unexplained weight loss
• New weakness, numbness, or loss of function
• Pain following injury or pain that is rapidly worsening

None of those are answered by a menopause average.

---

Why do some women have symptoms for much longer?

For frequent hot flashes and night sweats, the strongest predictor of a long course is early onset. SWAN also found associations with age, race and ethnicity, smoking history, education, financial strain, stress, anxiety, depressive symptoms, BMI, and symptom sensitivity at the first frequent-VMS report. These are population associations—not a formula, a verdict, or proof that a woman caused her own symptoms.

Factor in SWAN	Direction of association	Published figure or finding
Frequent VMS began before cycle changes or in early perimenopause	Longest course	More than 11.8 years total; 9.4 years after the final period
Frequent VMS began only after menopause	Shortest onset-stage course	Median 3.4 years
Younger age at first frequent-VMS report	Longer course	Association in adjusted models
Race and ethnicity, as population medians in this cohort	Duration differed by group	Black 10.1 years; Hispanic 8.9; White 6.5; Chinese 5.4; Japanese 4.8
Greater perceived stress, anxiety, depressive symptoms, and symptom sensitivity at onset	Longer course	Associations in adjusted models
Higher education, less financial strain, greater social support, and being married or partnered	Shorter course in parts of the analysis	Associations in adjusted models

Source: Avis et al., 2015.

On race and ethnicity

Those medians describe groups in one named U.S. cohort. They do not mean race itself is a personal biological stopwatch. Social conditions, chronic stress, discrimination, healthcare access, environment, health history, and biology can intersect. The study reports the disparity; it does not reduce an individual woman to the group median.

We include the numbers because hiding a difference of more than five years between the longest and shortest group medians would erase a real finding. We refuse to use them as destiny.

On stress and mood

Association is not blame.

Nobody gave herself an eleven-year course of hot flashes by failing to calm down. Symptoms are stressful. Stress can alter symptom perception and physiology. Social conditions shape stress. The relationship runs in more than one direction.

The stage clock also changes with age at onset

A separate SWAN analysis looked at the duration of the menopause transition, not the duration of hot flashes. The adjusted median transition ranged from 4.37 years in women in the oldest age-at-onset quartile to 8.57 years in the youngest. (Paramsothy et al., 2017)

That is another reason a generic four-year answer can feel insulting to someone who started early. It may be a reasonable midpoint for the stage overall and still be a poor description of her path.

Do not merge the two findings:

• 8.57 years is a transition-stage estimate in the youngest onset group.
• More than 11.8 years is a frequent-VMS estimate in the earliest symptom-onset group.

They are different clocks. The fact that both run longer with earlier onset is useful. Turning them into one number would recreate the exact problem this page is trying to fix.

---

What this page can't do

We'll be straight with you, because you've probably been handed enough false certainty already.

We cannot tell you when yours will stop. No clinician, blood test, or app can give you a reliable personal finish date. Hormone levels fluctuate during the usual transition, and the Office on Women's Health says blood hormone testing is generally not recommended just to determine whether a woman is near menopause unless there is another medical reason. (Office on Women's Health)

Anybody giving you an exact countdown is guessing.

But the date was never the most useful information.

The decisions in front of you—treat or wait, local or systemic, online or in person, investigate or monitor—depend more on:

• Which symptom is present
• How much it is affecting daily life
• Whether the symptom has evidence for spontaneous improvement or untreated progression
• Whether it could have another cause
• Your age, uterus and ovary status, medical history, medication preferences, insurance, and state

You cannot get a trustworthy end date. You can get a much better plan.

Turn the uncertainty into a starting point. Find My HRT Path gives you a private care-route match, two backup routes, and a safety flag when online care is not the right first step. No email is required to see the result.

---

Is it normal to still have menopause symptoms at 55, 60, or 65?

Continuing hot flashes or night sweats into the late fifties and sixties is documented. In a cross-sectional study of 10,418 British women aged 54–65 who were about ten years past menopause on average, 54% reported current hot flashes or night sweats. A new or meaningfully changed symptom still needs its own explanation rather than automatic labeling as menopause.

The study was published in BJOG in 2012. The women reported an average of 33 hot flashes or night sweats per week, and prevalence remained fairly even across the age range. The design was cross-sectional and the sample was predominantly White, so it does not tell every woman what will happen next. It does prove that persistent vasomotor symptoms in this age band were far from rare in that cohort. (Hunter et al., 2012)

This matters because women in this group can be dismissed in both directions:

• Real menopause symptoms are dismissed as “just aging.”
• New health problems are dismissed as “still menopause.”

Both are failures.

There is no automatic hormone-therapy stop age

The Menopause Society's position is individualized reassessment, not a mandatory stop at 60 or 65. Its 2022 position statement allows continuation beyond 65 after appropriate counseling and risk assessment; starting therapy at an older age or long after the final period is a separate risk-benefit question. (The Menopause Society)

GSM can become more prominent with time

Because GSM tends to progress untreated, vaginal, vulvar, sexual, and urinary symptoms may be part of the picture even after vasomotor symptoms have faded.

A new symptom at 62 is still a new symptom

Being postmenopausal does not turn every future symptom into menopause. The duration data validates persistence; it does not replace diagnosis.

---

Can menopause symptoms stop and then come back?

Yes. Symptoms can fluctuate during perimenopause, a quieter stretch does not prove the course has ended, and hot flashes can recur after hormone therapy is stopped. A returning symptom may fit the prior pattern; a new, severe, or clearly different symptom still deserves evaluation rather than being filed under menopause automatically.

Three versions of this happen in real life.

Natural fluctuation. Perimenopause is not a smooth downward slope. A good three months can be followed by a bad six weeks without either stretch telling you exactly where the finish line is.

One symptom eases while another becomes visible. Hot flashes settle and vaginal dryness becomes noticeable. Sleep improves while joint stiffness remains. It feels like whack-a-mole because different symptoms were never on one clock.

Return after treatment stops. Symptoms commonly recur after hormone therapy discontinuation. That does not prove treatment stored them up or extended menopause; it proves symptom suppression and symptom natural history are not the same thing.

The phrase to keep is this: return can happen; automatic attribution is still unsafe.

---

How long do symptoms last after a hysterectomy or surgical menopause?

Duration evidence is much weaker after hysterectomy or surgical menopause than it is for natural menopause. Removing both ovaries causes an abrupt fall in ovarian hormones and can cause sudden, stronger symptoms. A hysterectomy without ovary removal eliminates bleeding as a staging signal, so the standard last-period clock cannot determine where you are.

We're going to tell you the evidence is thinner here because it is. Confident numbers on other pages do not make the underlying data stronger.

The main VMS-duration medians do not attach cleanly

SWAN's main duration analysis used a natural-menopause framework and an observable final menstrual period for the post-period estimate. If you had your uterus removed, the bleeding marker is gone. If both ovaries were removed, the transition was abrupt rather than gradual.

Hysterectomy does not always mean surgical menopause

If the uterus is removed but one or both ovaries remain, ovarian hormone production can continue. You can be premenopausal, perimenopausal, or postmenopausal without periods to mark the change.

Removing both ovaries is different

The Office on Women's Health says removal of both ovaries causes hormone levels to drop quickly and may cause stronger menopause symptoms than natural menopause. (Office on Women's Health)

A tool should not guess your stage from a missing period

If bleeding is absent because of hysterectomy, hormonal contraception, an intrauterine system, another medication, or a medical condition, “months since last period” cannot independently establish menopause stage.

If this is you, our HRT after hysterectomy guide covers what changes about treatment, including why estrogen-only therapy may be considered after hysterectomy while exceptions still depend on the clinical history.

---

Is HRT just pushing the symptoms down the road?

Hormone therapy treats symptoms while you take it; it is not established to shorten or lengthen the underlying menopause transition. A 2025 systematic review found vasomotor symptoms after discontinuation were common, but its percentages are weighted averages across heterogeneous studies with an average participant age of 64.7—not a personal forecast.

This fear stops a lot of women from starting, and it deserves evidence instead of reassurance.

The review included 74 reports from 69 studies, covering 32,213 women and 2,943 healthcare professionals. The authors narratively synthesized the evidence and reported weighted averages where possible. (Bunnewell et al., 2025)

What the review measured	Weighted average or finding
Women who discontinued HRT in studies that measured continuation and discontinuation	51.3%
Average duration of use before stopping	5.4 years
Women who stopped abruptly	62.4%
Unspecified menopausal symptoms reported after stopping	84.4%
Sleep disturbance after stopping	51.9%
Hot flashes or night sweats after stopping	45.4%
Women who restarted	20.7%
Four randomized trials comparing tapering with abrupt stopping	Two found an early difference that disappeared after taper completion; two found no difference

Source: The HRT Index Editorial Team; see the primary sources linked in this section.

What those numbers tell you

Symptoms returning after discontinuation is common. Restarting is not rare. Tapering may change the immediate experience for some women, but the randomized trials did not show that tapering prevents symptoms once therapy is fully stopped.

What those numbers do not tell you

They do not tell you what your symptoms will do. The review combined studies with different designs, populations, products, durations, and outcomes. The average age was nearly 65. Many reports did not fully specify formulation or route.

They also cannot answer the impossible counterfactual: what would the same woman's untreated symptoms have done during the years she used therapy?

So here is the fair answer to “Is HRT just delaying it?”

Hormone therapy does not pause menopause. It treats symptoms. Symptoms may return when treatment stops, but the evidence cannot label them as symptoms you “postponed” versus symptoms you would have had anyway.

There is no universal stop date. Continuing, changing, tapering, or stopping is a periodic decision with a licensed clinician based on current benefits, risks, symptoms, age, time since menopause, and preferences. Our HRT benefits and risks guide covers that decision in depth.

---

When should you stop waiting for symptoms to pass?

A duration average is never a reason to tolerate symptoms that are seriously affecting sleep, work, mood, sex, relationships, or daily function. Bleeding after menopause, suspected menopause before 40, a new severe symptom, or a clearly progressive change should bypass the timeline and go to clinical evaluation.

⚠️ Do not wait this one out. Any vaginal bleeding or spotting after 12 months without a period should be evaluated by a healthcare professional. There are benign causes and serious causes. A duration article cannot tell you which one is present. (Office on Women's Health)

Other situations that need a clinician rather than a calculation:

Periods stopping before age 40. Menopause before 40 is considered premature; ages 40–45 are considered early. Both warrant assessment because the implications extend beyond current symptoms.

Heavy, prolonged, or clearly changed bleeding during perimenopause. Bleeding changes are common during the transition. Common does not mean every pattern should be assumed benign.

A new symptom that is severe, rapidly worsening, or different from your established pattern. Examples include unexplained weight loss, drenching night sweats with fever or swollen glands, one hot swollen joint, new neurologic symptoms, or clearly progressive cognitive change.

Symptoms that are wrecking daily life. You do not have to reach anyone's average before you are allowed to ask for help. There is no qualifying period. If it is bad enough that you're searching about it at 11 p.m., it is bad enough to bring to a clinician.

This list is not exhaustive and it is not a diagnostic tool. If something feels wrong, get it assessed.

---

What can you do while you're still in it?

You do not have to wait passively for a median to catch up with you. Tracking direction, documenting functional impact, and understanding the broad treatment categories before an appointment can turn “I feel awful” into a specific clinical conversation: what is most likely menopause-related, what needs another explanation, and what options fit your history.

Track change, not just presence

For four weeks, record:

• How many days the symptom occurred
• How often it woke you
• The worst episode and what it stopped you doing
• Whether it is improving, stable, worsening, or returning
• Bleeding pattern, if you still have periods
• Treatments, dose changes, and what changed afterward
• Anything you had to cancel, avoid, or recover from

That record is more useful than a long undifferentiated symptom list. It shows direction and cost.

Know the categories before you walk in

You do not need to arrive with a prescription request. You do need enough language to ask the right questions.

FDA-approved systemic hormone therapy. Estrogen, with endometrial protection for most women who have a uterus, is the most effective treatment for bothersome vasomotor symptoms. FDA-approved systemic products include pills, patches, gels, sprays, and other formulations. Product choice and eligibility depend on the clinical history.

FDA-approved nonhormonal prescription options for moderate-to-severe VMS. As of August 2026, the U.S. has three products approved specifically for this indication: low-dose paroxetine mesylate, fezolinetant, and elinzanetant. They are not interchangeable. Fezolinetant carries a boxed warning and liver-testing requirements; elinzanetant has its own contraindications, interactions, and warnings. A clinician must match the product to the person. (FDA Veozah safety communication; FDA Lynkuet snapshot)

FDA-approved prescription therapies for GSM. Local options can include low-dose vaginal estrogen and vaginal prasterone; oral ospemifene is a separate systemic option for specific symptoms. Which option fits depends on the symptom and clinical history.

Compounded products. Compounded medications are not FDA-approved. FDA does not verify their safety, effectiveness, or quality before marketing. They are not the same regulatory category as approved products and should not be described as equivalent, safer, or more natural. (FDA)

Treatment for a separate condition. Sleep apnea, thyroid disease, major depression, inflammatory arthritis, osteoarthritis, infection, and other diagnoses do not become menopause simply because they appear at the same age.

Five questions worth writing down

1. Which of my symptoms are most likely menopause-related, and which need another explanation?
2. Is anything in my pattern a reason for an examination, testing, or referral?
3. Which treatment categories fit my history and priorities?
4. How will we decide whether a treatment is working, and by when?
5. When will we reassess the plan?

---

Where can you get care if you've decided not to wait it out?

If you have decided not to ride out a symptom that may have years left, the practical question is which care model fits your insurance, state, symptoms, and need for a hands-on examination. Virtual menopause care can be a reasonable starting point for many women. It is the wrong starting point when the problem requires an exam, imaging, a procedure, or urgent evaluation.

Provider facts last verified August 4, 2026. Prices and coverage can change; confirm during booking.

This is the only section of the page with affiliate links.

We apply The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule. We evaluate providers on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not publish numeric provider scores because one number would hide the trade-offs that matter.

Verified decision point	Midi Health	Sesame menopause subscription
Care model	Virtual visits focused on midlife and menopause care	Virtual subscription; choose a participating clinician, with video visits as needed and unlimited messaging
State availability	Available in all 50 states; exact insurance participation and clinician availability still vary	Sesame markets the platform nationwide; confirm that a menopause clinician licensed in your state is available during signup
Published self-pay price	$250 initial visit; $150 continued-care visit	$59 per month
Insurance	In-network with most PPO plans; coverage, copays, coinsurance, and deductibles vary by plan	Does not bill health insurance for the subscription
Medicare / Medicaid	Not covered by Medicare; Medicare beneficiaries may self-pay but cannot submit related claims. Midi says it cannot treat Medicaid or Medi-Cal patients even as self-pay	Cash-pay subscription; medication or outside-lab coverage may still depend on the person's plan
Medication category and cost	Midi says clinicians prescribe FDA-approved hormonal and nonhormonal options when appropriate; the exact product and pharmacy cost depend on the prescription and insurance	Sesame lists hormonal and nonhormonal prescriptions when clinically appropriate; medication is not included, so confirm the exact product, FDA status, pharmacy, coverage, and cost if prescribed
Labs	Ordered based on the clinician's judgment; confirm cost and coverage before completing them	Listed basic labs are included when ordered in most states; NY, NJ, RI, and ND patients pay the lab directly. Lab network also varies in AZ, OK, SD, WI, and HI
Cancellation / refund detail	Cancel or reschedule at least 24 hours before the visit to avoid a cancellation fee; confirm the current fee amount during booking	Full subscription refund if canceled at least three hours before the initial visit; no first-month refund after that visit. Cancel before the next billing cycle to avoid future charges; prior months are nonrefundable
Best fit	You want menopause-focused virtual care and have a compatible PPO plan—or you accept the published self-pay rates	You want a predictable cash-pay virtual subscription and understand that medication costs are separate
Not the right first step when	You need a pelvic exam, biopsy, ultrasound, examination of a swollen joint, or another hands-on assessment	You need a hands-on exam, urgent evaluation, imaging, or a procedure; Sesame says severe or complex cases may require in-person care

Source: Midi pricing and insurance; Midi cancellation guidance; Sesame menopause subscription.

Midi is virtual. Here's when that is a dealbreaker.

A video visit cannot perform a pelvic examination, biopsy, ultrasound, or physical examination of a painful joint. If the decision depends on someone examining you, do not start by paying a virtual provider and hoping the missing step disappears.

That limitation does not make virtual care useless. For a woman whose main problem is established hot flashes, night sweats, sleep disruption linked to VMS, or discussion of starting or adjusting menopause therapy—and who does not need an examination first—the bottleneck may be access to a clinician willing and able to manage menopause care.

Sesame is not an in-person-exam shortcut on this page

The current $59 menopause subscription is virtual. Sesame's broader marketplace may show other visit types in some locations, but the menopause subscription itself should not be sold as a guaranteed route to an in-person pelvic exam or procedure.

Its current value is transparent cash pricing, ongoing virtual contact, and listed basic labs when ordered. The trade-offs are a recurring subscription, medication charged separately, state-specific lab exceptions, and refund limits after the first visit.

If Midi fits your insurance or you accept the published self-pay rates: check Midi coverage and current booking cost. If a $59 cash-pay virtual subscription fits your situation: check Sesame's current menopause-program availability. These are affiliate links. The HRT Index may earn a commission. See our affiliate disclosure. A licensed clinician makes every treatment decision.

---

What do clinicians and researchers actually say about symptom duration?

The strongest expert message is not that menopause has one average. It is that onset timing changes the vasomotor course, GSM follows a different natural history, and prolonged symptoms remain common in older postmenopausal women. Those are named, published findings—not customer testimonials and not proof of what one treatment will do for you.

We do not publish customer testimonials on a symptom-duration page. One woman's timeline cannot establish yours, and a treatment success story cannot prove duration, safety, or typical results.

What we can give you is attributable evidence:

• Nancy Avis and the SWAN investigators found frequent VMS lasted more than seven years for more than half the women studied and continued a median 4.5 years after the final menstrual period.
• The Menopause Society states that GSM usually worsens over time without treatment, unlike hot flashes, which typically improve.
• Myra Hunter and colleagues found current hot flashes or night sweats in 54% of a 10,418-woman British cohort aged 54–65, despite participants being about ten years postmenopausal on average.

That is the kind of social proof this page can use without quietly turning somebody else's experience into your prognosis.

---

How did The HRT Index verify this page?

We traced each duration figure to the symptom, threshold, population, starting line, and ending line it actually measured. We replaced older musculoskeletal prevalence figures with a 2026 meta-analysis, rechecked current federal menopause wording, verified current provider prices and policies, and marked where the research cannot support a personal countdown.

What we actually checked

• The original SWAN duration analysis behind the 7.4-, 4.5-, 9.4-, and more-than-11.8-year figures
• The definition of frequent VMS: symptoms on at least six days in the prior two weeks
• Current Office on Women's Health wording on perimenopause duration, postmenopausal hot flashes, hormone testing, and bleeding after menopause
• STRAW+10 staging language on VMS in late transition and the first two years after the final period
• The Menopause Society's current GSM progression statement
• SWAN and Penn evidence on cognitive change
• Current evidence on depression risk during the transition
• The 2026 musculoskeletal meta-analysis of 93,021 women
• The 2025 systematic review of hormone-therapy discontinuation
• Current FDA status of compounded medications and nonhormonal VMS drugs
• Midi and Sesame pricing, insurance, lab, and cancellation details as published on August 4, 2026

What we could not confirm

We did not find a large long-term study that supplies a dependable symptom-duration median for surgical menopause comparable with the natural-menopause SWAN estimate. We say the evidence is thin instead of filling the gap with a confident number.

We also did not find a defensible universal countdown for brain fog, sleep disruption, mood changes, joint pain, fatigue, libido changes, hair changes, or weight changes. Where the evidence shows a direction or a population prevalence, we label it that way rather than turning it into a personal promise.

What we do not do

We do not invent a clinician reviewer, first-person treatment experience, customer testimonial, medical diagnosis, or numeric provider score. This is editorial research and is not medically reviewed by a clinician. See our medical review policy.

How we make money

We may earn a commission through labeled provider links. Affiliate status does not change FDA status, study findings, or the need to disclose a material limitation. See our affiliate disclosure.

Found something wrong? Our corrections page explains how to report it and how we handle changes.

---

Frequently asked questions about how long menopause symptoms last

Do menopause symptoms ever completely go away?

Some do for many women; others may persist or worsen. Frequent hot flashes usually improve over time, but some women have them for many years. GSM often persists and usually worsens untreated. Brain fog, sleep, mood, joint pain, fatigue, and libido changes do not have one dependable universal endpoint.

How long do menopause symptoms last after your periods stop?

For frequent hot flashes and night sweats, the SWAN median was 4.5 years after the final menstrual period. Women whose frequent symptoms began before cycle changes or in early perimenopause had a median 9.4 years after the final period. Those figures do not apply to every symptom.

Can menopause symptoms last 10 years or more?

Yes. In SWAN, women whose frequent hot flashes or night sweats began before cycle changes or in early perimenopause had a median total duration of more than 11.8 years. Some women have vasomotor symptoms for decades. Ten years is documented, particularly with early onset, but it is not a forecast for every woman.

At what age do menopause symptoms usually stop?

There is no fixed age. The average age of natural menopause in the United States is 52, but symptoms can continue into the sixties and beyond. In one British cohort aged 54–65, 54% reported current hot flashes or night sweats. A new symptom at an older age still needs its own explanation.

Why did my symptoms get worse after my last period?

The first two years after the final menstrual period are part of the stage when vasomotor symptoms are most likely. Reaching twelve months without a period confirms natural menopause retrospectively; it does not guarantee symptom relief. If the change is severe, new, or different from your established pattern, get it assessed.

How do you know when menopause is over?

Menopause is a point reached after 12 consecutive months without bleeding or spotting in natural menopause. Everything after that is postmenopause. The transition stage ends, but postmenopause continues for the rest of life, and symptoms do not have to stop on the menopause date.

Do menopause symptoms come back if you stop HRT?

They can. A 2025 systematic review reported a weighted average of 45.4% for vasomotor symptoms after discontinuation and 20.7% for restarting therapy. The studies were heterogeneous and participants averaged 64.7 years old, so those figures are context, not an individual probability.

Does HRT make menopause last longer?

It is not established to lengthen the biological menopause transition. Hormone therapy treats symptoms while it is used. Symptoms may return after stopping, but the evidence cannot determine whether they were “postponed” or would have been present during the same years without treatment.

When does menopause brain fog go away?

There is no reliable universal countdown. SWAN found some perimenopause-related changes were temporary, while other research found verbal-learning difficulty into early postmenopause. Progressive, severe, or function-limiting cognitive change should be evaluated rather than automatically attributed to menopause.

Does vaginal dryness go away after menopause?

It may not. Vaginal, vulvar, sexual, and urinary symptoms grouped as GSM often persist, and The Menopause Society says the syndrome usually worsens over time without treatment. New symptoms still need the correct diagnosis before treatment is chosen.

Is bleeding after menopause part of the normal symptom timeline?

No. Bleeding or spotting after 12 months without a period needs medical evaluation. It is not a symptom to wait out against a menopause average.

Can menopause symptoms continue into your 60s or 70s?

Yes, especially vasomotor symptoms in some women and untreated GSM. Continuing symptoms are documented. That does not mean every symptom in later life is caused by menopause, and a new or clearly changed symptom should still be assessed.

Does a blood test show how much longer symptoms will last?

No. Hormone levels fluctuate during the usual transition, and no blood test reliably predicts when an individual's symptoms will end. Testing may be appropriate for a separate medical reason, especially when periods stop unusually early or the diagnosis is unclear.

How long do symptoms last after a hysterectomy?

The duration evidence is much weaker. If the uterus was removed but the ovaries remain, bleeding history cannot establish stage. If both ovaries were removed, symptoms can begin abruptly and may be stronger. A clinician who knows the surgical history is a better source than a generic duration median.

Do symptoms last longer if menopause started early?

For frequent hot flashes and night sweats, earlier onset is associated with a longer course. Women whose frequent symptoms began before cycle changes or in early perimenopause had a median duration greater than 11.8 years, compared with 3.4 years when frequent symptoms began only after menopause.

When should I seek help instead of waiting?

Seek clinical care when symptoms are substantially affecting daily life, when bleeding occurs after menopause, when periods stop before 40, or when a symptom is new, severe, progressive, or clearly different. You do not have to suffer until you reach anyone's average.

---

Where do you go from here?

If you take one thing from this page, take this:

Stop counting months and start sorting symptoms.

Frequent hot flashes have a measured duration, but a median is not a deadline. Cognitive, mood, sleep, and joint symptoms have more variable evidence and may need their own explanation. GSM usually worsens untreated, which turns waiting into an actual decision rather than a neutral default.

And if you're at year seven, eight, or ten and quietly wondering whether something is wrong with you, the short number you were given may have been measuring a different symptom or a different starting line.

Still not sure which HRT program is right for you? Take our free matching quiz—it takes about 90 seconds.

→ Take Find My HRT Path — a personalized starting-point plan, plus a flag when online care isn't the right first step.

---

Sources

1. Avis NE, Crawford SL, Greendale G, et al. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition. JAMA Internal Medicine. 2015;175(4):531–539.
2. National Institute on Aging. What Is Menopause?. Reviewed October 16, 2024; verified August 4, 2026.
3. Office on Women's Health. Menopause Basics. Updated April 2, 2026.
4. Office on Women's Health. Menopause Symptoms and Relief. Updated May 30, 2025.
5. Harlow SD, Gass M, Hall JE, et al. Executive Summary of STRAW+10. Menopause. 2012.
6. The Menopause Society. Hot Flashes. Verified August 4, 2026.
7. The Menopause Society. Genitourinary Syndrome of Menopause MenoNote. Verified August 4, 2026.
8. Greendale GA, Huang MH, Wight RG, et al. Effects of the Menopause Transition and Hormone Use on Cognitive Performance in Midlife Women. Neurology. 2009.
9. Epperson CN, Sammel MD, Freeman EW. Menopause Effects on Verbal Memory: Findings From a Longitudinal Community Cohort. Journal of Clinical Endocrinology & Metabolism. 2013.
10. Maki PM, et al. Brain Fog in Menopause: A Health-Care Professional's Guide. Climacteric. 2022.
11. Kravitz HM, Janssen I, Bromberger JT, et al. Sleep Trajectories Before and After the Final Menstrual Period in SWAN. Current Sleep Medicine Reports. 2017.
12. National Institute of Mental Health. Mood and Psychosis Symptoms During the Menopause Transition. Posted November 22, 2024.
13. 988 Suicide & Crisis Lifeline. Free, Confidential Support by Call, Text, or Chat. Verified August 4, 2026.
14. Kruse C, McKechnie T, Dworsky-Fried J, et al. Musculoskeletal Manifestations of Perimenopause: A Systematic Review and Meta-Analysis of 93,021 Women. JBJS Open Access. 2026.
15. Paramsothy P, Harlow SD, Greendale GA, et al. Duration of the Menopausal Transition Is Longer in Women With Young Age at Onset. Menopause. 2017;24(2):142–149.
16. Greendale GA, Sowers M, Han W, et al. Bone Mineral Density Loss in Relation to the Final Menstrual Period. Journal of Bone and Mineral Research. 2012.
17. Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, Frequency and Problem Rating of Hot Flushes Persist in Older Postmenopausal Women. BJOG. 2012;119(1):40–50.
18. Bunnewell S, Keating S, Parsons J, Hickey M, Hillman S. Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy: A Systematic Review. BJOG. 2025.
19. The Menopause Society. Ongoing Individualized Hormone Therapy Appears to Have No Age Limit. 2024.
20. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Verified August 4, 2026.
21. U.S. Food and Drug Administration. Brisdelle Prescribing Information. 2025.
22. U.S. Food and Drug Administration. FDA Adds Warning About Rare Serious Liver Injury With Veozah. Verified August 4, 2026.
23. U.S. Food and Drug Administration. Drug Trials Snapshot: Lynkuet. 2025.
24. Midi Health. Pricing and Insurance. Verified August 4, 2026.
25. Midi Health. Cancellation Guidance and Current Self-Pay Summary. Updated July 1, 2026; verified August 4, 2026.
26. Sesame Care. Online Menopause Treatment. Verified August 4, 2026.

Last verified August 2026. Next scheduled review November 2026.